Search

Nathaniel Herzfeld

Examiner (ID: 2727, Phone: (571)272-5899 , Office: P/3749 )

Most Active Art Unit
3762
Art Unit(s)
3743, 3749, 3762
Total Applications
626
Issued Applications
427
Pending Applications
1
Abandoned Applications
203

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18301108 [patent_doc_number] => 11622994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-11 [patent_title] => Therapy for vitiligo [patent_app_type] => utility [patent_app_number] => 15/714627 [patent_app_country] => US [patent_app_date] => 2017-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8660 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15714627 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/714627
Therapy for vitiligo Sep 24, 2017 Issued
Array ( [id] => 16954918 [patent_doc_number] => 11058746 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-13 [patent_title] => Use of immunomodulatory protein from [patent_app_type] => utility [patent_app_number] => 15/714218 [patent_app_country] => US [patent_app_date] => 2017-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 5 [patent_no_of_words] => 3192 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15714218 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/714218
Use of immunomodulatory protein from Sep 24, 2017 Issued
Array ( [id] => 15360943 [patent_doc_number] => 20200016236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => TREATMENT OF AGE-RELATED MACULAR DEGENERATION [patent_app_type] => utility [patent_app_number] => 16/335441 [patent_app_country] => US [patent_app_date] => 2017-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9059 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335441 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/335441
Treatment of age-related macular degeneration Sep 21, 2017 Issued
Array ( [id] => 12641238 [patent_doc_number] => 20180105577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => ALBUMIN VARIANTS [patent_app_type] => utility [patent_app_number] => 15/709261 [patent_app_country] => US [patent_app_date] => 2017-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26891 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709261 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/709261
ALBUMIN VARIANTS Sep 18, 2017 Abandoned
Array ( [id] => 12239929 [patent_doc_number] => 20180072792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'ALBUMIN VARIANTS' [patent_app_type] => utility [patent_app_number] => 15/709227 [patent_app_country] => US [patent_app_date] => 2017-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 28785 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709227 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/709227
ALBUMIN VARIANTS Sep 18, 2017 Abandoned
Array ( [id] => 12641241 [patent_doc_number] => 20180105578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => ALBUMIN VARIANTS [patent_app_type] => utility [patent_app_number] => 15/709263 [patent_app_country] => US [patent_app_date] => 2017-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27000 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 233 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709263 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/709263
ALBUMIN VARIANTS Sep 18, 2017 Abandoned
Array ( [id] => 12641235 [patent_doc_number] => 20180105576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => ALBUMIN VARIANTS [patent_app_type] => utility [patent_app_number] => 15/709169 [patent_app_country] => US [patent_app_date] => 2017-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26961 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709169 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/709169
ALBUMIN VARIANTS Sep 18, 2017 Abandoned
Array ( [id] => 12233168 [patent_doc_number] => 20180066031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'ENZYMATICALLY-CLEAVABLE PEPTIDE AMPHIPHILES' [patent_app_type] => utility [patent_app_number] => 15/693739 [patent_app_country] => US [patent_app_date] => 2017-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 15952 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15693739 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/693739
ENZYMATICALLY-CLEAVABLE PEPTIDE AMPHIPHILES Aug 31, 2017 Abandoned
Array ( [id] => 14621813 [patent_doc_number] => 20190224274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => MIF INHIBITORS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/330061 [patent_app_country] => US [patent_app_date] => 2017-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17346 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330061 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/330061
MIF INHIBITORS AND METHODS OF USE THEREOF Aug 30, 2017 Abandoned
Array ( [id] => 14896955 [patent_doc_number] => 20190292243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => PEPTIDES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/326154 [patent_app_country] => US [patent_app_date] => 2017-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38530 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326154 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/326154
PEPTIDES AND METHODS OF USE THEREOF Aug 21, 2017 Abandoned
Array ( [id] => 13702645 [patent_doc_number] => 20170362277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS [patent_app_type] => utility [patent_app_number] => 15/676851 [patent_app_country] => US [patent_app_date] => 2017-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23266 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15676851 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/676851
Cyclosporine analogue mixtures and their use as immunomodulating agents Aug 13, 2017 Issued
Array ( [id] => 17179376 [patent_doc_number] => 11156614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-26 [patent_title] => Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen [patent_app_type] => utility [patent_app_number] => 15/668101 [patent_app_country] => US [patent_app_date] => 2017-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7378 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15668101 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/668101
Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen Aug 2, 2017 Issued
Array ( [id] => 12051456 [patent_doc_number] => 20170327800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-16 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS' [patent_app_type] => utility [patent_app_number] => 15/663361 [patent_app_country] => US [patent_app_date] => 2017-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 36952 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15663361 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/663361
METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS Jul 27, 2017 Abandoned
Array ( [id] => 12030829 [patent_doc_number] => 20170320928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'ALPHA/BETA-POLYPEPTIDE ANALOGS OF GLUCAGON-LIKE PEPTIDE 1' [patent_app_type] => utility [patent_app_number] => 15/648937 [patent_app_country] => US [patent_app_date] => 2017-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11719 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648937 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/648937
Alpha/beta-polypeptide analogs of glucagon-like peptide 1 Jul 12, 2017 Issued
Array ( [id] => 18153171 [patent_doc_number] => 11566133 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-31 [patent_title] => Gelatin polymer derived from natural sources of cold-adapted marine species and uses thereof [patent_app_type] => utility [patent_app_number] => 16/310780 [patent_app_country] => US [patent_app_date] => 2017-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 52 [patent_no_of_words] => 20174 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310780 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/310780
Gelatin polymer derived from natural sources of cold-adapted marine species and uses thereof Jun 18, 2017 Issued
Array ( [id] => 11942088 [patent_doc_number] => 20170246240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'Antibacterial Peptide and Method of Treatment Using the Antibacterial Peptide' [patent_app_type] => utility [patent_app_number] => 15/595313 [patent_app_country] => US [patent_app_date] => 2017-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9425 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15595313 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/595313
Antibacterial peptide and method of treatment using the antibacterial peptide May 14, 2017 Issued
Array ( [id] => 15296049 [patent_doc_number] => 20190391160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => METHODS AND COMPOSITIONS FOR MODIFYING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR ACTIVITY [patent_app_type] => utility [patent_app_number] => 16/097293 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20010 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097293 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/097293
METHODS AND COMPOSITIONS FOR MODIFYING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR ACTIVITY Apr 27, 2017 Abandoned
Array ( [id] => 12023640 [patent_doc_number] => 20170313740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'METHODS OF PREPARING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 15/499793 [patent_app_country] => US [patent_app_date] => 2017-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21350 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15499793 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/499793
METHODS OF PREPARING PEPTIDES Apr 26, 2017 Abandoned
Array ( [id] => 16353107 [patent_doc_number] => 10793608 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-06 [patent_title] => Hypersensitive response elicitor-derived peptides and use thereof [patent_app_type] => utility [patent_app_number] => 15/476082 [patent_app_country] => US [patent_app_date] => 2017-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22775 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476082 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/476082
Hypersensitive response elicitor-derived peptides and use thereof Mar 30, 2017 Issued
Array ( [id] => 14230513 [patent_doc_number] => 20190127429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-02 [patent_title] => CONJUGATES OF ISLET NEOGENESIS PEPTIDES AND ANALOGS, AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 16/074073 [patent_app_country] => US [patent_app_date] => 2017-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7024 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074073 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/074073
Conjugates of islet neogenesis peptides and analogs, and methods thereof Mar 8, 2017 Issued
Menu